Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers

Antibodies to influenza surface protein neuraminidase (NA) have been found to reduce disease severity and may be an independent correlate of protection. Despite this, current influenza vaccines have no regulatory requirements for the quality or quantity of the NA antigen and are not optimized for in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Lena, Zhou, Fan, Amdam, Håkon, Trieu, Mai-Chi, Cox, Rebecca Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551669/
https://www.ncbi.nlm.nih.gov/pubmed/34721417
http://dx.doi.org/10.3389/fimmu.2021.748264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551669/
https://www.ncbi.nlm.nih.gov/pubmed/34721417
http://dx.doi.org/10.3389/fimmu.2021.748264

Ejemplares similares